Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Observational Study

Research Support, Non-U.S. Gov't

Multicenter Study

Clinical Trial, Phase III

Review

Randomized Controlled Trial

Clinical Trial

Research Support, N.I.H., Extramural

Clinical Trial, Phase II

Meta-Analysis

Comparative Study

Systematic Review

Case Reports

Research Support, U.S. Gov't, P.H.S.

Pragmatic Clinical Trial

Equivalence Trial

Controlled Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Sustained Virologic Response""[mesh_terms]

65 Results

Searching titles within these results

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.

André Gömer, Mara Klöhn, Michelle Jagst, Maximilian K Nocke, Sven Pischke, Thomas Horvatits, Julian Schulze Zur Wiesch, Tobias Müller, Svenja Hardtke, Markus Cornberg, Heiner Wedemeyer, Patrick Behrendt, Eike Steinmann, Daniel Todt

Hepatology (Baltimore, Md.) 2023;78(6):1882-1895

Free Full Text

Abstract

Adherence in Hepatitis C Virus Treatment: What We Know.

Alessandra Mangia, Steven L Flamm

Seminars in liver disease 2024;44(2):258-271

Full Text

Abstract

Current state-of-the-art pharmacotherapy for the management of hepatitis B infection.

Hans L Tillmann, Gbeminiyi Samuel

Expert opinion on pharmacotherapy 2019;20(7):873-885

Full Text

Abstract

Direct-acting antiviral treatment for patients with hepatocellular carcinoma.

Tatyana Kushner, Douglas Dieterich, Behnam Saberi

Current opinion in gastroenterology 2019;34(3):132-139

Full Text

Abstract

Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis.

Daniela C Diglio, Sabrina A Fernandes, Jessica Stein, André Azeredo-da-Silva, Angelo A de Mattos, Cristiane V Tovo

Annals of hepatology 2021;19(2):190-196

Free Full Text

Abstract

Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts.

Takanori Kanai, Karin Yamataka, Po-Sung Chu, Yuzo Koda, Nobuhito Taniki, Rei Morikawa, Aya Yoshida, Fumie Noguchi, Ryosuke Kasuga, Takaya Tabuchi, Hirotoshi Ebinuma, Nobuhiro Nakamoto

PloS one 2022;17(10):e0276925

Free Full Text

Abstract

Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational study.

Georgios Angelidakis, Haley Pritchard, Marcel Yibirin, Ying Jiang, Khalis Mustafayev, Harrys A Torres

Diagnostic microbiology and infectious disease 2022;103(3):115719

Full Text

Abstract

Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.

Marcel Yibirin, Khalis Mustafayev, Jeff Hosry, Pooja Pundhir, Joseph Klingen, Eduardo Yepez Guevara, Bruno P Granwehr, Ahmed Kaseb, Aung Naing, Sapna Patel, Amishi Y Shah, Ferdinandos Skoulidis, Hussein A Tawbi, Lan Wang, Ethan Miller, Hao Chi Zhang, Amado Zurita-Saavedra, Harrys A Torres

The American journal of gastroenterology 2023;118(9):1609-1617

Free Full Text

Abstract

Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance.

Deanna D Hill, Jennifer R Kramer, Kassie R Chaffin, T Christopher Mast, Michael N Robertson, Fasiha Kanwal, Barbara A Haber

Annals of hepatology 2023;28(2):100899

Free Full Text

Abstract

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b.

Tatsuo Kanda, Kazushige Nirei, Naoki Matsumoto, Teruhisa Higuchi, Hitomi Nakamura, Hiroaki Yamagami, Shunichi Matsuoka, Mitsuhiko Moriyama

World journal of gastroenterology 2018;23(46):8120-8127

Free Full Text

Abstract

Treatment and re-treatment results of HCV patients in the DAA era.

Felix Piecha, Jan-Michael Gänßler, Ann-Kathrin Ozga, Malte H Wehmeyer, Julia Dietz, Johannes Kluwe, Alena Laschtowitz, Johann von Felden, Martina Sterneck, Sabine Jordan, Sven Pischke, Ansgar W Lohse, Julian Schulze Zur Wiesch

PloS one 2020;15(5):e0232773

Free Full Text

Abstract

Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals.

Marc Deschenes, Philip Wong, Felice Cinque, Annalisa Cespiati, Rosa Lombardi, Mohamed Shengir, Agnihotram V Ramanakumar, Anna Ludovica Fracanzani, Wesal Elgretli, Tianyan Chen, Giada Sebastiani, Luz Ballesteros

Clinics and research in hepatology and gastroenterology 2025;49(7):102639

Free Full Text

Abstract

Hepatitis delta and HIV infection.

Kenneth E Sherman, Pablo Barreiro, Vincent Soriano

AIDS (London, England) 2018;31(7):875-884

Full Text

Abstract

Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.

Marina Serper, Donna M Evon, Jipcy Amador, Paul W Stewart, Souvik Sarkar, Anna S Lok, Richard K Sterling, Bryce B Reeve, Carol E Golin, K Rajender Reddy, Joseph K Lim, Nancy Reau, David R Nelson, Adrian M Di Bisceglie, Michael W Fried

Liver international : official journal of the International Association for the Study of the Liver 2021;41(4):692-704

Free Full Text

Abstract

Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

Atsuyuki Ikeda, Kaori Ikeda, Atsushi Takai, Ken Takahashi, Yoshihide Ueda, Hiroyuki Marusawa, Horoshi Seno, Nobuya Inagaki, Hiroyuki Kokuryu

Digestion 2019;96(4):228-230

Full Text

Abstract

Results: 1 – 15 / 65

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Sustained Virologic Response""[mesh_terms]

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.

Adherence in Hepatitis C Virus Treatment: What We Know.

Current state-of-the-art pharmacotherapy for the management of hepatitis B infection.

Direct-acting antiviral treatment for patients with hepatocellular carcinoma.

Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis.

Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts.

Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational study.

Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.

Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance.

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b.

Treatment and re-treatment results of HCV patients in the DAA era.

Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals.

Hepatitis delta and HIV infection.

Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.

Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

Results for
""Sustained Virologic Response""[mesh_terms]